サワイグループホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/09/11 | 4,438 | 4,449 | 4,297 | 4,328 | -68 | -1.5% | 203,400 |
| 2023/09/08 | 4,306 | 4,402 | 4,306 | 4,396 | +63 | +1.5% | 657,300 |
| 2023/09/07 | 4,364 | 4,377 | 4,261 | 4,333 | -48 | -1.1% | 801,500 |
| 2023/09/06 | 4,360 | 4,399 | 4,256 | 4,381 | -96 | -2.1% | 1,213,500 |
| 2023/09/05 | 4,716 | 4,716 | 4,435 | 4,477 | -239 | -5.1% | 1,164,400 |
| 2023/09/04 | 4,729 | 4,730 | 4,680 | 4,716 | -6 | -0.1% | 405,600 |
| 2023/09/01 | 4,685 | 4,727 | 4,636 | 4,722 | +44 | +0.9% | 305,800 |
| 2023/08/31 | 4,665 | 4,729 | 4,631 | 4,678 | +133 | +2.9% | 573,500 |
| 2023/08/30 | 4,476 | 4,563 | 4,431 | 4,545 | +17 | +0.4% | 214,300 |
| 2023/08/29 | 4,450 | 4,600 | 4,447 | 4,528 | +90 | +2% | 316,300 |
| 2023/08/28 | 4,440 | 4,451 | 4,383 | 4,438 | +20 | +0.5% | 169,400 |
| 2023/08/25 | 4,473 | 4,474 | 4,397 | 4,418 | -60 | -1.3% | 209,800 |
| 2023/08/24 | 4,429 | 4,481 | 4,386 | 4,478 | +38 | +0.9% | 309,300 |
| 2023/08/23 | 4,412 | 4,441 | 4,337 | 4,440 | +20 | +0.5% | 483,500 |
| 2023/08/22 | 4,453 | 4,503 | 4,371 | 4,420 | +271 | +6.5% | 652,200 |
| 2023/08/21 | 4,078 | 4,221 | 4,070 | 4,149 | +1 | ±0% | 418,500 |
| 2023/08/18 | 4,008 | 4,252 | 3,986 | 4,148 | +117 | +2.9% | 821,900 |
| 2023/08/17 | 3,892 | 4,039 | 3,853 | 4,031 | +149 | +3.8% | 731,000 |
| 2023/08/16 | 3,735 | 3,896 | 3,708 | 3,882 | +137 | +3.7% | 465,600 |
| 2023/08/15 | 3,676 | 3,754 | 3,643 | 3,745 | +90 | +2.5% | 378,100 |
| 2023/08/14 | 3,715 | 3,728 | 3,607 | 3,655 | -60 | -1.6% | 284,300 |
| 2023/08/10 | 3,555 | 3,716 | 3,537 | 3,715 | +196 | +5.6% | 574,600 |
| 2023/08/09 | 3,528 | 3,547 | 3,373 | 3,519 | -13 | -0.4% | 482,800 |
| 2023/08/08 | 3,517 | 3,550 | 3,507 | 3,532 | ±0 | ±0% | 298,700 |
| 2023/08/07 | 3,500 | 3,554 | 3,484 | 3,532 | +26 | +0.7% | 199,700 |
| 2023/08/04 | 3,495 | 3,509 | 3,473 | 3,506 | +11 | +0.3% | 177,100 |
| 2023/08/03 | 3,533 | 3,540 | 3,486 | 3,495 | -54 | -1.5% | 299,500 |
| 2023/08/02 | 3,554 | 3,578 | 3,536 | 3,549 | -26 | -0.7% | 227,500 |
| 2023/08/01 | 3,580 | 3,595 | 3,564 | 3,575 | +30 | +0.8% | 138,300 |
| 2023/07/31 | 3,582 | 3,585 | 3,540 | 3,545 | +18 | +0.5% | 111,500 |
| 2023/07/28 | 3,510 | 3,536 | 3,494 | 3,527 | -33 | -0.9% | 196,400 |
| 2023/07/27 | 3,565 | 3,565 | 3,510 | 3,560 | -6 | -0.2% | 130,100 |
| 2023/07/26 | 3,535 | 3,566 | 3,511 | 3,566 | +22 | +0.6% | 119,100 |
| 2023/07/25 | 3,532 | 3,546 | 3,504 | 3,544 | +12 | +0.3% | 143,500 |
| 2023/07/24 | 3,494 | 3,535 | 3,476 | 3,532 | +71 | +2.1% | 129,800 |
| 2023/07/21 | 3,421 | 3,461 | 3,411 | 3,461 | +44 | +1.3% | 170,400 |
| 2023/07/20 | 3,464 | 3,488 | 3,415 | 3,417 | -96 | -2.7% | 196,600 |
| 2023/07/19 | 3,538 | 3,544 | 3,490 | 3,513 | -8 | -0.2% | 122,000 |
| 2023/07/18 | 3,502 | 3,540 | 3,500 | 3,521 | +19 | +0.5% | 106,100 |
| 2023/07/14 | 3,485 | 3,518 | 3,466 | 3,502 | -21 | -0.6% | 201,400 |
| 2023/07/13 | 3,532 | 3,559 | 3,511 | 3,523 | -4 | -0.1% | 77,800 |
| 2023/07/12 | 3,518 | 3,550 | 3,510 | 3,527 | -17 | -0.5% | 131,500 |
| 2023/07/11 | 3,597 | 3,611 | 3,533 | 3,544 | -72 | -2% | 163,900 |
| 2023/07/10 | 3,634 | 3,649 | 3,604 | 3,616 | -28 | -0.8% | 141,400 |
| 2023/07/07 | 3,588 | 3,644 | 3,551 | 3,644 | +42 | +1.2% | 174,900 |
| 2023/07/06 | 3,633 | 3,647 | 3,591 | 3,602 | -40 | -1.1% | 111,300 |
| 2023/07/05 | 3,625 | 3,648 | 3,621 | 3,642 | +14 | +0.4% | 86,700 |
| 2023/07/04 | 3,630 | 3,650 | 3,602 | 3,628 | +7 | +0.2% | 159,300 |
| 2023/07/03 | 3,642 | 3,669 | 3,621 | 3,621 | -4 | -0.1% | 179,100 |
| 2023/06/30 | 3,629 | 3,646 | 3,590 | 3,625 | -30 | -0.8% | 304,400 |
401～
450
件表示中 / 1000件
類似銘柄と比較する
現在ご覧いただいている「サワイＧＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サワイＧＨＤ | 203,300円 | +4.0% | +25.4% | 2.61% | 8.89倍 | 1.17倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| ペプチド | 201,800円 | +5.0% | +1.5% | 0.00% | 17.33倍 | 4.61倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 科研薬 | 407,200円 | +30.5% | +111.0% | 4.67% | 11.48倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 379,500円 | +14.5% | -2.3% | 2.37% | 13.88倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム
